Dr. Nitesh Rohatgi
MBBS, DNB (Medical Oncology), MNAMS, M Med Oncology (Dundee), CCT, MRCP, FRCP (Edinburgh), FRSM
Senior Director, Medical Oncology
corporate_fareFortis Memorial Research Institute, Gurugram
Nitesh Rohatgi
MBBS, DNB (Medical Oncology), MNAMS, M Med Oncology (Dundee), CCT, MRCP, FRCP (Edinburgh), FRSM
Dr. Nitesh Rohatgi is a Senior Director of Medical Oncology at Fortis Memorial Research Institute, Gurugram, with over two decades of experience in systemic cancer treatment. His clinical work encompasses chemotherapy, immunotherapy, targeted therapy, precision oncology and palliative medicine for a broad range of solid tumours.
Dr. Rohatgi has built his oncology career across both Indian and UK institutions, holding previous positions at St James's Institute of Oncology, Leeds, and the London Oncology Clinic at Harley Street, London. His subspecialty interests include molecularly guided treatment planning, NGS-based genomic profiling and quality-of-life focused cancer care. He holds fellowships from the Royal College of Physicians, Edinburgh, and the Royal Society of Medicine, reflecting his engagement with international oncology standards. He was recognised as an invited faculty member at the Excellence in Oncology Care 2025 conference for his contributions to breast cancer care.
CancerFax can coordinate medical-record review, case preparation and consultation support for international patients seeking an opinion from Dr. Rohatgi at Fortis Memorial Research Institute, Gurugram.
Why Consider Dr. Nitesh Rohatgi?
Dr. Rohatgi combines over two decades of oncology practice with international training across India and the UK, offering patients access to precision-based systemic cancer treatment at a leading tertiary cancer centre.
Areas of Specialization
Precision-driven medical oncology spanning solid tumours and systemic cancer management
Dr. Rohatgi's clinical focus covers the full range of systemic oncology treatments, with an emphasis on molecularly guided therapy selection and quality-of-life integration throughout the cancer care journey.
Precision Oncology & Targeted Therapy
Genomic and biomarker-driven approaches to systemic cancer treatment planning.
- arrow_rightNext-generation sequencing-based treatment planning for solid tumours
- arrow_rightLiquid and tissue biopsy-based comprehensive molecular profiling
- arrow_rightBiomarker-driven targeted agent selection
- arrow_rightTargeted agents for breast, lung, gastrointestinal and genitourinary cancers
- arrow_rightMolecularly matched therapy planning in collaboration with pathology
Immunotherapy & Systemic Treatment
Checkpoint inhibitor-based immunotherapy and advanced systemic protocols for eligible patients.
- arrow_rightPD-1 and PD-L1 inhibitor-based treatment for suitable solid tumour patients
- arrow_rightImmune-related adverse event monitoring and management
- arrow_rightStandard and dose-dense chemotherapy protocols for multiple cancer types
- arrow_rightManagement of neutropenic sepsis, anti-emesis and anaphylaxis
Palliative Oncology & Supportive Care
Integrating quality-of-life focused care with active cancer management.
- arrow_rightSymptom control and supportive care during active systemic treatment
- arrow_rightLong-term care planning for patients with advanced or metastatic cancers
Procedures Performed
Clinical services and systemic treatment approaches at Fortis Memorial Research Institute, Gurugram
Dr. Rohatgi manages the full cycle of systemic cancer treatment, from initial staging and molecular workup through active treatment, response monitoring and supportive care planning.
Systemic Cancer Treatment
Medical OncologyChemotherapy, hormone therapy and combination regimen planning for a broad range of solid tumours.
Targeted & Immunotherapy
Targeted TherapyBiomarker-guided targeted agents and checkpoint inhibitor immunotherapy for eligible patients.
Diagnosis & Molecular Workup
DiagnosisComprehensive molecular and pathological assessment to guide treatment planning.
Treatment Monitoring & Follow-up
MonitoringOngoing response assessment and toxicity monitoring throughout systemic treatment.
Second Opinion & Complex Case Review
Second OpinionExpert review for patients with advanced or refractory cancers seeking independent treatment guidance.
Research & Publications
Peer-reviewed publications and clinical research contributions in medical oncology
Dr. Rohatgi has contributed to clinical research in oncology, with publications in peer-reviewed journals and involvement in molecular profiling studies. A more detailed publication list is available on request.
A detailed publication list and trial participation history can be requested through CancerFax as part of the case-review process.
Education & Training
Dr. Rohatgi completed his medical training in India before undertaking advanced oncology qualifications in the United Kingdom, including an M Med Oncology from the University of Dundee and a Certificate of Completion of Training through the UK specialty pathway. He holds fellowships from the Royal College of Physicians, Edinburgh, and the Royal Society of Medicine.
Clinical Experience
Dr. Rohatgi has over two decades of medical oncology experience spanning leading cancer institutions in both India and the United Kingdom. He currently leads Medical Oncology at Fortis Memorial Research Institute, Gurugram, one of India's premier tertiary cancer centres.
Languages & International
Dr. Rohatgi consults in English and Hindi.
CancerFax can coordinate professional medical interpreter support for international patients where required.
CancerFax can coordinate professional medical interpreter support for international patients consulting in other languages.
How CancerFax Helps You Access Dr. Nitesh Rohatgi
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Nitesh Rohatgi's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Nitesh Rohatgi's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Nitesh Rohatgi before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Nitesh Rohatgi's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Nitesh Rohatgi's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Nitesh Rohatgi's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Nitesh Rohatgi
Dr. Nitesh Rohatgi is a Senior Director of Medical Oncology at Fortis Memorial Research Institute, Gurugram. With over two decades of oncology experience, he specialises in chemotherapy, immunotherapy, targeted therapy and precision oncology. He is a Fellow of the Royal College of Physicians, Edinburgh, and the Royal Society of Medicine, UK, and has practised at leading cancer centres in both India and the United Kingdom.
Dr. Rohatgi treats a wide range of solid tumours including breast cancer, lung cancer, gastrointestinal cancers (colorectal, gastric, oesophageal and pancreatic), gynaecological cancers, head and neck cancers, genitourinary cancers (kidney, bladder and prostate), hepatobiliary cancers and brain tumours. He also has reported experience in teenage and young adult oncology.
Yes. Dr. Rohatgi uses next-generation sequencing (NGS) and comprehensive molecular profiling from liquid and tissue samples to identify biomarkers and guide targeted therapy selection. This precision oncology approach allows treatment to be tailored to the specific molecular profile of each patient's tumour.
International patients can seek consultation with Dr. Rohatgi through CancerFax. CancerFax can coordinate medical-record review, case preparation and consultation support for patients seeking a remote second opinion or planning to travel to Fortis Memorial Research Institute, Gurugram, subject to hospital availability and case acceptance.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history and relevant test results. The CancerFax team will prepare the case and coordinate submission to Dr. Rohatgi's team at Fortis Memorial Research Institute. The consultation format and availability depend on the hospital schedule.
Submit your medical reports through the CancerFax platform. The team will review the documents, prepare a structured medical summary and coordinate the next steps with Fortis Memorial Research Institute, Gurugram, subject to availability. For urgent cases, please indicate this clearly in your submission.
Connect with Nitesh Rohatgi Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.